论文部分内容阅读
目的：分析研讨依达拉奉联合七叶皂苷钠治疗脑出血的临床疗效。方法采用随机抽签方式，从我院2013年2月至2016年6月期间收治的脑出血患者中，抽取128例纳入到研讨范围中，再次依据入院顺序分两组，64例对照组和64例研究组，对照组七叶皂苷钠治疗，研究组接受依达拉奉联合七叶皂苷钠治疗，将治疗状况纳入到对比讨论中。结果对比两组患者治疗前DNS评分状况，组间数据无统计学意义（P＞0．05）；对比两组患者治疗后14天、治疗后28天，研究组比对照组优，组间数据有统计学意义（P＜0．05）。研究组治疗总有效率92．19％比对照组81．25％要高，组间数据有统计学意义（P＜0．05）。结论临床治疗脑出血疾病可考虑将依达拉奉和七叶皂苷钠药物联合使用，疗效突出，血肿和脑水肿改善明显，推广应用价值高。“,”Objective to analyze the clinical curative ef ect of edaravone on disease combined with seven yezao sodium in the treatment of cerebral hemorrhage.Methods by random draw,from the intracerebral hemorrhage patients admit ed to our hospital in February 2013 to 2016 during the month of June,selected 128 cases included in the scope of the study again accord-ing to the order of admission points in two groups,64 cases of control group and 64 cases in the study group,control group,sodium aescinate treatment,study group received edaravone com-bined with sodium aescinate treatment,treatment status into to compare and discuss.Results the treatment and the status of DNS scores were compared between the two groups of patients.The data among groups were no statistical significance(P>0.05);compared with two groups of patients after 14 days,28 days after treatment study group than the control group,the data between the groups has statistical significance(P<0.05).The total efective rate of the study group was 81.25% higher than that of the control group(92.19%),and the data were statistically signifi-cant(P<0.05).Conclusion for clinical treatment of cerebral hemorrhage disease can consider to be combined use of Edaravone and sodium aescinate drug,prominent curative efect,signifi-cantly improved the hematoma and cerebral edema,popularization and application value.